

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.99427247 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.99427247 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.76519610 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.76519610 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.21474431 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.94653856 |
| 7 | negative regulation of fibrinolysis (GO:0051918) | 5.64834049 |
| 8 | glyoxylate metabolic process (GO:0046487) | 5.62823271 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 5.61457163 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.60271790 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 5.53861642 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.53861642 |
| 13 | tryptophan catabolic process (GO:0006569) | 5.53861642 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.47251490 |
| 15 | urea cycle (GO:0000050) | 5.41803111 |
| 16 | urea metabolic process (GO:0019627) | 5.41803111 |
| 17 | protein carboxylation (GO:0018214) | 5.31441452 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.31441452 |
| 19 | regulation of fibrinolysis (GO:0051917) | 5.29185710 |
| 20 | tryptophan metabolic process (GO:0006568) | 5.25177625 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.24048278 |
| 22 | regulation of protein activation cascade (GO:2000257) | 5.22307442 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.16574209 |
| 24 | cysteine metabolic process (GO:0006534) | 5.12368412 |
| 25 | complement activation, alternative pathway (GO:0006957) | 5.10853797 |
| 26 | serine family amino acid catabolic process (GO:0009071) | 5.02914339 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.91550363 |
| 28 | regulation of complement activation (GO:0030449) | 4.88705110 |
| 29 | basement membrane organization (GO:0071711) | 4.83620745 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.81369752 |
| 31 | reverse cholesterol transport (GO:0043691) | 4.72938256 |
| 32 | bile acid metabolic process (GO:0008206) | 4.66727754 |
| 33 | lysine metabolic process (GO:0006553) | 4.62672256 |
| 34 | lysine catabolic process (GO:0006554) | 4.62672256 |
| 35 | glycine metabolic process (GO:0006544) | 4.55217877 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.53194740 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 4.46709491 |
| 38 | negative regulation of cholesterol transport (GO:0032375) | 4.46492818 |
| 39 | negative regulation of sterol transport (GO:0032372) | 4.46492818 |
| 40 | tyrosine metabolic process (GO:0006570) | 4.42293736 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.41953712 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 4.41953712 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.41953712 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 4.40944250 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.40558120 |
| 46 | triglyceride homeostasis (GO:0070328) | 4.40558120 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 4.40512700 |
| 48 | alpha-amino acid catabolic process (GO:1901606) | 4.37141063 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 4.36386964 |
| 50 | plasma lipoprotein particle clearance (GO:0034381) | 4.33853400 |
| 51 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 4.18888720 |
| 52 | imidazole-containing compound metabolic process (GO:0052803) | 4.17914735 |
| 53 | phospholipid efflux (GO:0033700) | 4.17817829 |
| 54 | serine family amino acid metabolic process (GO:0009069) | 4.13654176 |
| 55 | fibrinolysis (GO:0042730) | 4.08310870 |
| 56 | cellular amino acid catabolic process (GO:0009063) | 4.00806376 |
| 57 | ethanol oxidation (GO:0006069) | 3.97792016 |
| 58 | regulation of cholesterol homeostasis (GO:2000188) | 3.96326132 |
| 59 | glutamate metabolic process (GO:0006536) | 3.95377615 |
| 60 | bile acid and bile salt transport (GO:0015721) | 3.94562276 |
| 61 | serine family amino acid biosynthetic process (GO:0009070) | 3.94446652 |
| 62 | cellular modified amino acid catabolic process (GO:0042219) | 3.94243707 |
| 63 | arginine metabolic process (GO:0006525) | 3.89760950 |
| 64 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.89200629 |
| 65 | cholesterol efflux (GO:0033344) | 3.84692073 |
| 66 | coenzyme catabolic process (GO:0009109) | 3.83815117 |
| 67 | indolalkylamine metabolic process (GO:0006586) | 3.83208706 |
| 68 | regulation of apoptotic cell clearance (GO:2000425) | 3.82207715 |
| 69 | cellular glucuronidation (GO:0052695) | 3.80683824 |
| 70 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.80371702 |
| 71 | cellular ketone body metabolic process (GO:0046950) | 3.78698905 |
| 72 | plasma lipoprotein particle assembly (GO:0034377) | 3.77403848 |
| 73 | benzene-containing compound metabolic process (GO:0042537) | 3.77334118 |
| 74 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.69021498 |
| 75 | amine catabolic process (GO:0009310) | 3.67002557 |
| 76 | cellular biogenic amine catabolic process (GO:0042402) | 3.67002557 |
| 77 | semaphorin-plexin signaling pathway (GO:0071526) | 3.65210892 |
| 78 | endodermal cell differentiation (GO:0035987) | 3.61408326 |
| 79 | cholesterol homeostasis (GO:0042632) | 3.61033033 |
| 80 | positive regulation of lipid catabolic process (GO:0050996) | 3.59878666 |
| 81 | phospholipid homeostasis (GO:0055091) | 3.58733169 |
| 82 | drug catabolic process (GO:0042737) | 3.56395910 |
| 83 | sterol homeostasis (GO:0055092) | 3.56013761 |
| 84 | lipoprotein metabolic process (GO:0042157) | 3.55420030 |
| 85 | aldehyde catabolic process (GO:0046185) | 3.55120611 |
| 86 | acetyl-CoA metabolic process (GO:0006084) | 3.52904767 |
| 87 | low-density lipoprotein particle remodeling (GO:0034374) | 3.52861548 |
| 88 | blood coagulation, intrinsic pathway (GO:0007597) | 3.51310035 |
| 89 | complement activation, classical pathway (GO:0006958) | 3.50483112 |
| 90 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.50090908 |
| 91 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.50090908 |
| 92 | negative regulation of lipase activity (GO:0060192) | 3.48489321 |
| 93 | response to nitrosative stress (GO:0051409) | 3.48188796 |
| 94 | complement activation (GO:0006956) | 3.48053819 |
| 95 | regulation of bile acid biosynthetic process (GO:0070857) | 3.47129982 |
| 96 | adherens junction assembly (GO:0034333) | 3.46056679 |
| 97 | regulation of plasminogen activation (GO:0010755) | 3.45991744 |
| 98 | carboxylic acid catabolic process (GO:0046395) | 3.44952951 |
| 99 | organic acid catabolic process (GO:0016054) | 3.44952951 |
| 100 | protein activation cascade (GO:0072376) | 3.44356254 |
| 101 | protein-lipid complex assembly (GO:0065005) | 3.42994058 |
| 102 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.40991604 |
| 103 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.40889807 |
| 104 | epithelial cell-cell adhesion (GO:0090136) | 3.39544039 |
| 105 | atrioventricular valve morphogenesis (GO:0003181) | 3.38063443 |
| 106 | plasma lipoprotein particle organization (GO:0071827) | 3.34026747 |
| 107 | uronic acid metabolic process (GO:0006063) | 3.31904427 |
| 108 | glucuronate metabolic process (GO:0019585) | 3.31904427 |
| 109 | cytolysis (GO:0019835) | 3.31543615 |
| 110 | aspartate family amino acid catabolic process (GO:0009068) | 3.29543784 |
| 111 | cell-substrate junction assembly (GO:0007044) | 3.29026628 |
| 112 | endothelium development (GO:0003158) | 3.25714176 |
| 113 | branching involved in salivary gland morphogenesis (GO:0060445) | 3.20676462 |
| 114 | focal adhesion assembly (GO:0048041) | 3.20091525 |
| 115 | cell-substrate adherens junction assembly (GO:0007045) | 3.20091525 |
| 116 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.19249233 |
| 117 | negative regulation of fatty acid transport (GO:2000192) | 3.14586109 |
| 118 | regulation of cardioblast differentiation (GO:0051890) | 3.10068208 |
| 119 | paraxial mesoderm development (GO:0048339) | 3.02998103 |
| 120 | COPI coating of Golgi vesicle (GO:0048205) | 3.01338859 |
| 121 | Golgi transport vesicle coating (GO:0048200) | 3.01338859 |
| 122 | gap junction assembly (GO:0016264) | 3.00259178 |
| 123 | protein retention in ER lumen (GO:0006621) | 3.00023917 |
| 124 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.99417714 |
| 125 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.97076776 |
| 126 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.96181790 |
| 127 | convergent extension (GO:0060026) | 2.94868837 |
| 128 | desmosome organization (GO:0002934) | 2.91185983 |
| 129 | apoptotic process involved in morphogenesis (GO:0060561) | 2.91164132 |
| 130 | hemidesmosome assembly (GO:0031581) | 2.89190336 |
| 131 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.87209583 |
| 132 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.86127539 |
| 133 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.83134652 |
| 134 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.82328901 |
| 135 | positive regulation of receptor recycling (GO:0001921) | 2.80628487 |
| 136 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.79518320 |
| 137 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.73974947 |
| 138 | renal filtration (GO:0097205) | 2.73632695 |
| 139 | establishment of apical/basal cell polarity (GO:0035089) | 2.73073201 |
| 140 | protein heterotrimerization (GO:0070208) | 2.71730517 |
| 141 | chondrocyte proliferation (GO:0035988) | 2.69169685 |
| 142 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.68862344 |
| 143 | regulation of extracellular matrix disassembly (GO:0010715) | 2.68015013 |
| 144 | blood vessel endothelial cell migration (GO:0043534) | 2.67962726 |
| 145 | skin morphogenesis (GO:0043589) | 2.67904622 |
| 146 | * collagen metabolic process (GO:0032963) | 2.63513642 |
| 147 | cell migration involved in heart development (GO:0060973) | 2.60882490 |
| 148 | cell-cell junction maintenance (GO:0045217) | 2.60734226 |
| 149 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.60690410 |
| 150 | cell adhesion mediated by integrin (GO:0033627) | 2.58366623 |
| 151 | collagen fibril organization (GO:0030199) | 2.57689661 |
| 152 | regulation of establishment of planar polarity (GO:0090175) | 2.56830404 |
| 153 | * extracellular matrix disassembly (GO:0022617) | 2.56492465 |
| 154 | lymphangiogenesis (GO:0001946) | 2.55707075 |
| 155 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.52176804 |
| 156 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.51423347 |
| 157 | * multicellular organismal macromolecule metabolic process (GO:0044259) | 2.50642048 |
| 158 | cell proliferation involved in metanephros development (GO:0072203) | 2.49068420 |
| 159 | glomerular filtration (GO:0003094) | 2.48873828 |
| 160 | negative regulation of blood coagulation (GO:0030195) | 2.47011867 |
| 161 | negative regulation of hemostasis (GO:1900047) | 2.47011867 |
| 162 | apoptotic cell clearance (GO:0043277) | 2.44383297 |
| 163 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.43699145 |
| 164 | * collagen catabolic process (GO:0030574) | 2.43262789 |
| 165 | glomerular visceral epithelial cell development (GO:0072015) | 2.42708600 |
| 166 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.42242883 |
| 167 | negative regulation of cell fate specification (GO:0009996) | 2.41501492 |
| 168 | wound healing, spreading of epidermal cells (GO:0035313) | 2.41486101 |
| 169 | positive regulation of osteoblast proliferation (GO:0033690) | 2.39716059 |
| 170 | negative regulation of lipid transport (GO:0032369) | 2.38558693 |
| 171 | non-canonical Wnt signaling pathway (GO:0035567) | 2.37939795 |
| 172 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.37719588 |
| 173 | proline metabolic process (GO:0006560) | 2.37627682 |
| 174 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.36273253 |
| 175 | negative regulation of catenin import into nucleus (GO:0035414) | 2.35875851 |
| 176 | * multicellular organismal metabolic process (GO:0044236) | 2.34088458 |
| 177 | protein localization to endosome (GO:0036010) | 2.34068264 |
| 178 | negative regulation of wound healing (GO:0061045) | 2.32647513 |
| 179 | endothelial cell chemotaxis (GO:0035767) | 2.32594423 |
| 180 | positive regulation of hormone metabolic process (GO:0032352) | 2.32507189 |
| 181 | glomerular basement membrane development (GO:0032836) | 2.32390929 |
| 182 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.30307098 |
| 183 | venous blood vessel morphogenesis (GO:0048845) | 2.30209671 |
| 184 | * endothelial cell morphogenesis (GO:0001886) | 2.30081386 |
| 185 | negative regulation of coagulation (GO:0050819) | 2.30062477 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.49291162 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.57306057 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.86081231 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.64257218 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.89288514 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.56382866 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.17020499 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.81663517 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.15165914 |
| 10 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.60831074 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.58689491 |
| 12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.29374723 |
| 13 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.27396883 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11756256 |
| 15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.02969626 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.6886104 |
| 17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.99408369 |
| 18 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.96626383 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.96037297 |
| 20 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.92387634 |
| 21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.90232548 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.89904673 |
| 23 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.88811098 |
| 24 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.77285324 |
| 25 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.76085454 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.75252248 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.74614282 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67215191 |
| 29 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.63857140 |
| 30 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.59981395 |
| 31 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58898801 |
| 32 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.49541404 |
| 33 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.48665524 |
| 34 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.47084032 |
| 35 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.44700008 |
| 36 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.40849824 |
| 37 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.39760437 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36660492 |
| 39 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34427593 |
| 40 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.32622608 |
| 41 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.31824588 |
| 42 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.29628879 |
| 43 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.29388312 |
| 44 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.28533708 |
| 45 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.25376185 |
| 46 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.25266911 |
| 47 | MYC_22102868_ChIP-Seq_BL_Human | 1.22208399 |
| 48 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19988311 |
| 49 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19443721 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16965182 |
| 51 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.16952520 |
| 52 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.16952000 |
| 53 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.16941261 |
| 54 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16625816 |
| 55 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16600305 |
| 56 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.15393572 |
| 57 | P68_20966046_ChIP-Seq_HELA_Human | 1.14364186 |
| 58 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.13570535 |
| 59 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.12802688 |
| 60 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.12439629 |
| 61 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11738094 |
| 62 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11580423 |
| 63 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.11398254 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10442039 |
| 65 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.10209005 |
| 66 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.09142019 |
| 67 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.06837641 |
| 68 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.06837641 |
| 69 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.06837641 |
| 70 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.05081778 |
| 71 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03850554 |
| 72 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00940128 |
| 73 | * NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.00872850 |
| 74 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.00414108 |
| 75 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98930277 |
| 76 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.98845778 |
| 77 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98504402 |
| 78 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.97439059 |
| 79 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97434816 |
| 80 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97291288 |
| 81 | GATA1_22025678_ChIP-Seq_K562_Human | 0.96935388 |
| 82 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96551496 |
| 83 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95837549 |
| 84 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.95543038 |
| 85 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.95225352 |
| 86 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90848612 |
| 87 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89665676 |
| 88 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89326884 |
| 89 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.86543797 |
| 90 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86492261 |
| 91 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.84754883 |
| 92 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.84439468 |
| 93 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.82928411 |
| 94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.82187068 |
| 95 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.81746641 |
| 96 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.81657202 |
| 97 | ATF3_27146783_Chip-Seq_COLON_Human | 0.81453023 |
| 98 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.80614479 |
| 99 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.78056232 |
| 100 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.77843907 |
| 101 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77515763 |
| 102 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.74077618 |
| 103 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.73447240 |
| 104 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73115693 |
| 105 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.72856407 |
| 106 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.72589666 |
| 107 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.72435737 |
| 108 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.71468856 |
| 109 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.70976131 |
| 110 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70752625 |
| 111 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.70269249 |
| 112 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69527289 |
| 113 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.68838884 |
| 114 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.68275634 |
| 115 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.68134922 |
| 116 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.66343859 |
| 117 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.66040225 |
| 118 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.64624843 |
| 119 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.64590780 |
| 120 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64557203 |
| 121 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.64483715 |
| 122 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.64469239 |
| 123 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.62217423 |
| 124 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.61802087 |
| 125 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.61531830 |
| 126 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.60188001 |
| 127 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.60086641 |
| 128 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.59873878 |
| 129 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.59873878 |
| 130 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.59031764 |
| 131 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.58995934 |
| 132 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.58951593 |
| 133 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.58277749 |
| 134 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.58179843 |
| 135 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.58136013 |
| 136 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57805106 |
| 137 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.56933149 |
| 138 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.55536651 |
| 139 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.55420436 |
| 140 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.55315127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.50682554 |
| 2 | MP0005360_urolithiasis | 6.84582690 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.73572745 |
| 4 | MP0005365_abnormal_bile_salt | 5.48311512 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.23428056 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.94365722 |
| 7 | MP0003252_abnormal_bile_duct | 3.83287712 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.30042425 |
| 9 | MP0009840_abnormal_foam_cell | 2.87185736 |
| 10 | MP0005083_abnormal_biliary_tract | 2.84889178 |
| 11 | MP0003279_aneurysm | 2.77185271 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.66716180 |
| 13 | MP0003195_calcinosis | 2.59080383 |
| 14 | MP0005332_abnormal_amino_acid | 2.50876561 |
| 15 | MP0005257_abnormal_intraocular_pressure | 2.45778957 |
| 16 | MP0004858_abnormal_nervous_system | 2.35925083 |
| 17 | MP0005409_darkened_coat_color | 2.28977072 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.27403663 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.14148332 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 2.01344602 |
| 21 | MP0000609_abnormal_liver_physiology | 2.00848322 |
| 22 | MP0010368_abnormal_lymphatic_system | 1.96775952 |
| 23 | MP0000751_myopathy | 1.94934544 |
| 24 | MP0000566_synostosis | 1.90817893 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.89455413 |
| 26 | MP0005503_abnormal_tendon_morphology | 1.80049076 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.78274496 |
| 28 | MP0001958_emphysema | 1.77679596 |
| 29 | MP0005076_abnormal_cell_differentiation | 1.70595381 |
| 30 | MP0003091_abnormal_cell_migration | 1.67975596 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.67586676 |
| 32 | MP0003941_abnormal_skin_development | 1.66257367 |
| 33 | MP0003868_abnormal_feces_composition | 1.63456705 |
| 34 | MP0002089_abnormal_postnatal_growth/wei | 1.56372828 |
| 35 | MP0009053_abnormal_anal_canal | 1.48819129 |
| 36 | MP0005623_abnormal_meninges_morphology | 1.46662847 |
| 37 | MP0002254_reproductive_system_inflammat | 1.38384955 |
| 38 | MP0006138_congestive_heart_failure | 1.37671688 |
| 39 | MP0000678_abnormal_parathyroid_gland | 1.34120405 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.34085614 |
| 41 | MP0009697_abnormal_copulation | 1.27505152 |
| 42 | MP0005508_abnormal_skeleton_morphology | 1.27359635 |
| 43 | MP0000003_abnormal_adipose_tissue | 1.23974485 |
| 44 | MP0000598_abnormal_liver_morphology | 1.22747983 |
| 45 | MP0009643_abnormal_urine_homeostasis | 1.22151761 |
| 46 | MP0010630_abnormal_cardiac_muscle | 1.18405146 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.17796016 |
| 48 | MP0000013_abnormal_adipose_tissue | 1.17685366 |
| 49 | * MP0001614_abnormal_blood_vessel | 1.15385593 |
| 50 | MP0002877_abnormal_melanocyte_morpholog | 1.14845840 |
| 51 | MP0005451_abnormal_body_composition | 1.14444583 |
| 52 | MP0003011_delayed_dark_adaptation | 1.13485438 |
| 53 | MP0003385_abnormal_body_wall | 1.13307868 |
| 54 | MP0002108_abnormal_muscle_morphology | 1.10741410 |
| 55 | MP0002925_abnormal_cardiovascular_devel | 1.09468336 |
| 56 | MP0010234_abnormal_vibrissa_follicle | 1.09276458 |
| 57 | MP0002933_joint_inflammation | 1.08148631 |
| 58 | MP0005647_abnormal_sex_gland | 1.07819174 |
| 59 | MP0001764_abnormal_homeostasis | 1.06053429 |
| 60 | MP0005595_abnormal_vascular_smooth | 1.05468091 |
| 61 | MP0008438_abnormal_cutaneous_collagen | 1.05103398 |
| 62 | MP0000462_abnormal_digestive_system | 1.04023453 |
| 63 | MP0000428_abnormal_craniofacial_morphol | 1.04010649 |
| 64 | MP0001299_abnormal_eye_distance/ | 1.03765574 |
| 65 | MP0003186_abnormal_redox_activity | 1.03576140 |
| 66 | MP0006054_spinal_hemorrhage | 1.03153014 |
| 67 | MP0008260_abnormal_autophagy | 1.02248052 |
| 68 | MP0004084_abnormal_cardiac_muscle | 1.02003985 |
| 69 | MP0002896_abnormal_bone_mineralization | 0.98697873 |
| 70 | MP0001348_abnormal_lacrimal_gland | 0.98375343 |
| 71 | * MP0004272_abnormal_basement_membrane | 0.97731168 |
| 72 | MP0003942_abnormal_urinary_system | 0.97642454 |
| 73 | MP0000534_abnormal_ureter_morphology | 0.97290296 |
| 74 | MP0000762_abnormal_tongue_morphology | 0.95409104 |
| 75 | MP0005670_abnormal_white_adipose | 0.93809590 |
| 76 | MP0002932_abnormal_joint_morphology | 0.93024184 |
| 77 | MP0005375_adipose_tissue_phenotype | 0.92337414 |
| 78 | MP0003283_abnormal_digestive_organ | 0.92167860 |
| 79 | MP0005330_cardiomyopathy | 0.91147874 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.87098111 |
| 81 | MP0009763_increased_sensitivity_to | 0.86642863 |
| 82 | MP0000049_abnormal_middle_ear | 0.86190391 |
| 83 | MP0000858_altered_metastatic_potential | 0.85201596 |
| 84 | MP0004087_abnormal_muscle_fiber | 0.85140669 |
| 85 | MP0001661_extended_life_span | 0.83804832 |
| 86 | MP0005023_abnormal_wound_healing | 0.83549582 |
| 87 | MP0000733_abnormal_muscle_development | 0.82460263 |
| 88 | MP0003828_pulmonary_edema | 0.79884996 |
| 89 | MP0005275_abnormal_skin_tensile | 0.78803736 |
| 90 | MP0003566_abnormal_cell_adhesion | 0.78432168 |
| 91 | MP0005248_abnormal_Harderian_gland | 0.77564129 |
| 92 | MP0002295_abnormal_pulmonary_circulatio | 0.77399574 |
| 93 | MP0002796_impaired_skin_barrier | 0.77346586 |
| 94 | MP0005220_abnormal_exocrine_pancreas | 0.76294872 |
| 95 | MP0005408_hypopigmentation | 0.76058873 |
| 96 | MP0003329_amyloid_beta_deposits | 0.75928847 |
| 97 | MP0009780_abnormal_chondrocyte_physiolo | 0.75642536 |
| 98 | MP0002060_abnormal_skin_morphology | 0.74799545 |
| 99 | MP0001915_intracranial_hemorrhage | 0.74290751 |
| 100 | MP0003935_abnormal_craniofacial_develop | 0.73777865 |
| 101 | MP0000604_amyloidosis | 0.73692342 |
| 102 | MP0000432_abnormal_head_morphology | 0.72530709 |
| 103 | MP0000266_abnormal_heart_morphology | 0.72264445 |
| 104 | MP0009672_abnormal_birth_weight | 0.71086624 |
| 105 | MP0004233_abnormal_muscle_weight | 0.70966477 |
| 106 | MP0003984_embryonic_growth_retardation | 0.70325743 |
| 107 | MP0003656_abnormal_erythrocyte_physiolo | 0.68784306 |
| 108 | MP0009384_cardiac_valve_regurgitation | 0.68243917 |
| 109 | MP0009764_decreased_sensitivity_to | 0.67878266 |
| 110 | MP0000537_abnormal_urethra_morphology | 0.67158646 |
| 111 | MP0005666_abnormal_adipose_tissue | 0.65497175 |
| 112 | MP0009642_abnormal_blood_homeostasis | 0.65206259 |
| 113 | MP0001756_abnormal_urination | 0.63785290 |
| 114 | MP0002168_other_aberrant_phenotype | 0.63766400 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 0.63465474 |
| 116 | MP0005395_other_phenotype | 0.63278414 |
| 117 | MP0005376_homeostasis/metabolism_phenot | 0.62077738 |
| 118 | MP0004130_abnormal_muscle_cell | 0.60973645 |
| 119 | MP0003115_abnormal_respiratory_system | 0.59455590 |
| 120 | MP0004264_abnormal_extraembryonic_tissu | 0.58532465 |
| 121 | MP0005636_abnormal_mineral_homeostasis | 0.55690765 |
| 122 | MP0002136_abnormal_kidney_physiology | 0.55562706 |
| 123 | MP0002971_abnormal_brown_adipose | 0.54959996 |
| 124 | MP0008469_abnormal_protein_level | 0.54535181 |
| 125 | MP0001243_abnormal_dermal_layer | 0.53583523 |
| 126 | MP0002928_abnormal_bile_duct | 0.53249545 |
| 127 | MP0005266_abnormal_metabolism | 0.53178705 |
| 128 | MP0001849_ear_inflammation | 0.52646564 |
| 129 | MP0005334_abnormal_fat_pad | 0.51656956 |
| 130 | MP0002697_abnormal_eye_size | 0.50712749 |
| 131 | MP0000639_abnormal_adrenal_gland | 0.50464075 |
| 132 | MP0009765_abnormal_xenobiotic_induced | 0.49995938 |
| 133 | MP0005084_abnormal_gallbladder_morpholo | 0.49694878 |
| 134 | MP0000579_abnormal_nail_morphology | 0.49230333 |
| 135 | MP0002128_abnormal_blood_circulation | 0.49016134 |
| 136 | MP0010352_gastrointestinal_tract_polyps | 0.48955022 |
| 137 | MP0002078_abnormal_glucose_homeostasis | 0.48711966 |
| 138 | MP0003300_gastrointestinal_ulcer | 0.48424577 |
| 139 | MP0010030_abnormal_orbit_morphology | 0.45950772 |
| 140 | MP0004185_abnormal_adipocyte_glucose | 0.45933892 |
| 141 | MP0002092_abnormal_eye_morphology | 0.45066502 |
| 142 | MP0002135_abnormal_kidney_morphology | 0.44697151 |
| 143 | MP0002282_abnormal_trachea_morphology | 0.44578265 |
| 144 | MP0000467_abnormal_esophagus_morphology | 0.44184385 |
| 145 | MP0000767_abnormal_smooth_muscle | 0.44043819 |
| 146 | MP0004197_abnormal_fetal_growth/weight/ | 0.43648214 |
| 147 | MP0003119_abnormal_digestive_system | 0.42659579 |
| 148 | MP0005187_abnormal_penis_morphology | 0.42224835 |
| 149 | MP0005501_abnormal_skin_physiology | 0.41473951 |
| 150 | MP0000249_abnormal_blood_vessel | 0.39950566 |
| 151 | MP0002086_abnormal_extraembryonic_tissu | 0.39445791 |
| 152 | MP0001879_abnormal_lymphatic_vessel | 0.38905957 |
| 153 | MP0002249_abnormal_larynx_morphology | 0.38292882 |
| 154 | MP0003638_abnormal_response/metabolism_ | 0.38007730 |
| 155 | MP0004883_abnormal_blood_vessel | 0.37916736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.47909707 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.00706213 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.57394728 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.57134608 |
| 5 | Xanthomatosis (HP:0000991) | 6.04104141 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.96244987 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.69794693 |
| 8 | Premature rupture of membranes (HP:0001788) | 5.21534498 |
| 9 | Complement deficiency (HP:0004431) | 5.08441239 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.94852353 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.62413601 |
| 12 | Epidermoid cyst (HP:0200040) | 4.31573260 |
| 13 | Hyperammonemia (HP:0001987) | 4.28749797 |
| 14 | Joint hemorrhage (HP:0005261) | 4.26536198 |
| 15 | Hypoalphalipoproteinemia (HP:0003233) | 4.19321794 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.18286735 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.17507435 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.11253992 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.05241976 |
| 20 | Hyperglycinemia (HP:0002154) | 4.04495003 |
| 21 | Abnormality of complement system (HP:0005339) | 3.81516023 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 3.79717666 |
| 23 | Ketosis (HP:0001946) | 3.76293229 |
| 24 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.75255630 |
| 25 | Cerebral aneurysm (HP:0004944) | 3.74253245 |
| 26 | Hyperglycinuria (HP:0003108) | 3.72534881 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.70369774 |
| 28 | Fat malabsorption (HP:0002630) | 3.69393421 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.61707423 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.61707423 |
| 31 | Shallow orbits (HP:0000586) | 3.54038769 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.53619429 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.45663765 |
| 34 | Hypoglycemic coma (HP:0001325) | 3.43811469 |
| 35 | Hepatocellular carcinoma (HP:0001402) | 3.28003703 |
| 36 | Spastic diplegia (HP:0001264) | 3.16164577 |
| 37 | Cervical subluxation (HP:0003308) | 3.10941413 |
| 38 | Aortic dissection (HP:0002647) | 3.10445265 |
| 39 | Myocardial infarction (HP:0001658) | 3.09544864 |
| 40 | Arterial tortuosity (HP:0005116) | 2.94548609 |
| 41 | Ulnar bowing (HP:0003031) | 2.92670988 |
| 42 | Atrophic scars (HP:0001075) | 2.91365256 |
| 43 | Conjugated hyperbilirubinemia (HP:0002908) | 2.90214904 |
| 44 | Esophageal varix (HP:0002040) | 2.88151809 |
| 45 | Broad metatarsal (HP:0001783) | 2.85715431 |
| 46 | Skin nodule (HP:0200036) | 2.85421770 |
| 47 | Abnormality of nucleobase metabolism (HP:0010932) | 2.84863387 |
| 48 | Hyperbilirubinemia (HP:0002904) | 2.83418239 |
| 49 | Vascular tortuosity (HP:0004948) | 2.82280593 |
| 50 | Delayed CNS myelination (HP:0002188) | 2.80778424 |
| 51 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.80551767 |
| 52 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.77692465 |
| 53 | Spontaneous abortion (HP:0005268) | 2.76550206 |
| 54 | Fragile skin (HP:0001030) | 2.73063539 |
| 55 | Mitral valve prolapse (HP:0001634) | 2.72330923 |
| 56 | Spinal rigidity (HP:0003306) | 2.72204766 |
| 57 | Hypochromic microcytic anemia (HP:0004840) | 2.70840777 |
| 58 | Vascular calcification (HP:0004934) | 2.69726620 |
| 59 | Ankle contracture (HP:0006466) | 2.67227003 |
| 60 | Increased connective tissue (HP:0009025) | 2.66595621 |
| 61 | Steatorrhea (HP:0002570) | 2.66241173 |
| 62 | Blue sclerae (HP:0000592) | 2.64832832 |
| 63 | Abnormality of serum amino acid levels (HP:0003112) | 2.59202115 |
| 64 | Cardiovascular calcification (HP:0011915) | 2.56078348 |
| 65 | Disproportionate tall stature (HP:0001519) | 2.55585428 |
| 66 | Aortic aneurysm (HP:0004942) | 2.55181598 |
| 67 | Ketoacidosis (HP:0001993) | 2.54426525 |
| 68 | Biconcave vertebral bodies (HP:0004586) | 2.54266914 |
| 69 | Bronchomalacia (HP:0002780) | 2.53289494 |
| 70 | Bladder diverticulum (HP:0000015) | 2.51763214 |
| 71 | Malnutrition (HP:0004395) | 2.44276616 |
| 72 | Hemorrhage of the eye (HP:0011885) | 2.41447071 |
| 73 | Abnormality of purine metabolism (HP:0004352) | 2.39667265 |
| 74 | Neonatal short-limb short stature (HP:0008921) | 2.38401102 |
| 75 | Abnormality of dentin (HP:0010299) | 2.36055439 |
| 76 | Wormian bones (HP:0002645) | 2.35102939 |
| 77 | Glomerulonephritis (HP:0000099) | 2.34666273 |
| 78 | Aneurysm (HP:0002617) | 2.34510142 |
| 79 | Broad face (HP:0000283) | 2.33846779 |
| 80 | Neonatal onset (HP:0003623) | 2.33295281 |
| 81 | Wrist flexion contracture (HP:0001239) | 2.33159596 |
| 82 | Soft skin (HP:0000977) | 2.32360509 |
| 83 | Gout (HP:0001997) | 2.32073825 |
| 84 | Systemic lupus erythematosus (HP:0002725) | 2.31197716 |
| 85 | Mitral stenosis (HP:0001718) | 2.28527223 |
| 86 | Vertebral compression fractures (HP:0002953) | 2.28399601 |
| 87 | Increased variability in muscle fiber diameter (HP:0003557) | 2.28341854 |
| 88 | Pseudobulbar signs (HP:0002200) | 2.27560564 |
| 89 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.26156624 |
| 90 | Back pain (HP:0003418) | 2.24622429 |
| 91 | Flat acetabular roof (HP:0003180) | 2.21002128 |
| 92 | Cholelithiasis (HP:0001081) | 2.20646374 |
| 93 | Nonimmune hydrops fetalis (HP:0001790) | 2.19996773 |
| 94 | Abnormal gallbladder morphology (HP:0012437) | 2.19239820 |
| 95 | Nephritis (HP:0000123) | 2.17059551 |
| 96 | Hyperacusis (HP:0010780) | 2.15694774 |
| 97 | Metabolic acidosis (HP:0001942) | 2.15640828 |
| 98 | Acanthocytosis (HP:0001927) | 2.10649955 |
| 99 | Distal upper limb amyotrophy (HP:0007149) | 2.10598943 |
| 100 | Upper limb amyotrophy (HP:0009129) | 2.10598943 |
| 101 | Hypoglycemic seizures (HP:0002173) | 2.10567345 |
| 102 | Enlarged kidneys (HP:0000105) | 2.09483358 |
| 103 | Distal lower limb amyotrophy (HP:0008944) | 2.09089647 |
| 104 | Asymmetry of the thorax (HP:0001555) | 2.09060084 |
| 105 | Obstructive sleep apnea (HP:0002870) | 2.06665927 |
| 106 | Abnormal cartilage morphology (HP:0002763) | 2.05283835 |
| 107 | Focal segmental glomerulosclerosis (HP:0000097) | 2.05124736 |
| 108 | Dilatation of the ascending aorta (HP:0005111) | 2.04158577 |
| 109 | Amyloidosis (HP:0011034) | 2.04153951 |
| 110 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.03783386 |
| 111 | Dicarboxylic aciduria (HP:0003215) | 2.03783386 |
| 112 | Lethargy (HP:0001254) | 2.03694441 |
| 113 | Hydroxyprolinuria (HP:0003080) | 2.03526616 |
| 114 | Abnormality of proline metabolism (HP:0010907) | 2.03526616 |
| 115 | Genu recurvatum (HP:0002816) | 2.02535834 |
| 116 | Late onset (HP:0003584) | 2.02118167 |
| 117 | Irritability (HP:0000737) | 2.00618336 |
| 118 | Joint laxity (HP:0001388) | 2.00030921 |
| 119 | Aplasia involving bones of the extremities (HP:0009825) | 1.99352604 |
| 120 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.99352604 |
| 121 | Aplasia of the phalanges of the hand (HP:0009802) | 1.99352604 |
| 122 | Cholecystitis (HP:0001082) | 1.98323093 |
| 123 | Abnormal gallbladder physiology (HP:0012438) | 1.98323093 |
| 124 | Turricephaly (HP:0000262) | 1.97833451 |
| 125 | Glomerulosclerosis (HP:0000096) | 1.97753058 |
| 126 | Thrombophlebitis (HP:0004418) | 1.97253340 |
| 127 | Achilles tendon contracture (HP:0001771) | 1.96933193 |
| 128 | Metaphyseal cupping (HP:0003021) | 1.96796436 |
| 129 | Thin ribs (HP:0000883) | 1.96374994 |
| 130 | Abnormal delivery (HP:0001787) | 1.95411413 |
| 131 | Coxa vara (HP:0002812) | 1.95308755 |
| 132 | Type 1 muscle fiber predominance (HP:0003803) | 1.94892462 |
| 133 | Protrusio acetabuli (HP:0003179) | 1.93681061 |
| 134 | Stroke (HP:0001297) | 1.93136551 |
| 135 | Mitral regurgitation (HP:0001653) | 1.92311300 |
| 136 | Abnormality of the acetabulum (HP:0003170) | 1.91523149 |
| 137 | Abnormality of the Achilles tendon (HP:0005109) | 1.91033749 |
| 138 | Premature skin wrinkling (HP:0100678) | 1.90357258 |
| 139 | Menorrhagia (HP:0000132) | 1.89630475 |
| 140 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.89218764 |
| 141 | Rickets (HP:0002748) | 1.88879320 |
| 142 | Neonatal death (HP:0003811) | 1.88458186 |
| 143 | Hyperextensible skin (HP:0000974) | 1.88384164 |
| 144 | Abnormality of iron homeostasis (HP:0011031) | 1.88345099 |
| 145 | Hemangiomatosis (HP:0007461) | 1.88199082 |
| 146 | Distal lower limb muscle weakness (HP:0009053) | 1.87533783 |
| 147 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87458991 |
| 148 | Coronal craniosynostosis (HP:0004440) | 1.85922354 |
| 149 | Abnormal vertebral ossification (HP:0100569) | 1.85870371 |
| 150 | Thin bony cortex (HP:0002753) | 1.84997785 |
| 151 | Arnold-Chiari malformation (HP:0002308) | 1.84085951 |
| 152 | Gingival bleeding (HP:0000225) | 1.83374275 |
| 153 | Increased mean platelet volume (HP:0011877) | 1.83194826 |
| 154 | Reticulocytosis (HP:0001923) | 1.81630323 |
| 155 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80743386 |
| 156 | Sensorimotor neuropathy (HP:0007141) | 1.78848583 |
| 157 | Visceral angiomatosis (HP:0100761) | 1.78538953 |
| 158 | Stridor (HP:0010307) | 1.78082669 |
| 159 | Abnormality of the gallbladder (HP:0005264) | 1.75651460 |
| 160 | Wide anterior fontanel (HP:0000260) | 1.75593441 |
| 161 | Pancreatitis (HP:0001733) | 1.73857964 |
| 162 | J-shaped sella turcica (HP:0002680) | 1.73090203 |
| 163 | Vertebral clefting (HP:0008428) | 1.73024296 |
| 164 | Advanced eruption of teeth (HP:0006288) | 1.72740909 |
| 165 | * Ectopia lentis (HP:0001083) | 1.72517326 |
| 166 | Difficulty climbing stairs (HP:0003551) | 1.70607779 |
| 167 | Joint stiffness (HP:0001387) | 1.68368931 |
| 168 | Bowing of the arm (HP:0006488) | 1.68148711 |
| 169 | Bowed forearm bones (HP:0003956) | 1.68148711 |
| 170 | Neoplasm of the liver (HP:0002896) | 1.67574890 |
| 171 | Venous insufficiency (HP:0005293) | 1.67334527 |
| 172 | Selective tooth agenesis (HP:0001592) | 1.66647851 |
| 173 | Choanal stenosis (HP:0000452) | 1.66579960 |
| 174 | Polycythemia (HP:0001901) | 1.66198273 |
| 175 | Venous abnormality (HP:0002624) | 1.65709618 |
| 176 | Right ventricular cardiomyopathy (HP:0011663) | 1.65410007 |
| 177 | Peritonitis (HP:0002586) | 1.65043248 |
| 178 | Brushfield spots (HP:0001088) | 1.64849983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.56729879 |
| 2 | SIK1 | 3.82191494 |
| 3 | ERN1 | 3.73368520 |
| 4 | FGFR4 | 3.52781160 |
| 5 | PKN2 | 3.37062496 |
| 6 | LATS1 | 3.12680021 |
| 7 | TRIB3 | 3.08996841 |
| 8 | SMG1 | 2.94482699 |
| 9 | EPHA2 | 2.86285611 |
| 10 | PTK6 | 2.39446713 |
| 11 | ERBB4 | 2.22116497 |
| 12 | TIE1 | 2.19780167 |
| 13 | MAP3K10 | 2.17718354 |
| 14 | NTRK1 | 2.15041163 |
| 15 | RIPK1 | 1.99616399 |
| 16 | FLT3 | 1.87836236 |
| 17 | KDR | 1.74744054 |
| 18 | CDK12 | 1.69724059 |
| 19 | PDGFRA | 1.63794820 |
| 20 | EPHB2 | 1.55191028 |
| 21 | MET | 1.52873609 |
| 22 | STK38L | 1.52800969 |
| 23 | PTK2 | 1.51405563 |
| 24 | TTN | 1.41863916 |
| 25 | MST1R | 1.36452958 |
| 26 | PAK4 | 1.35390025 |
| 27 | CDC42BPA | 1.31042514 |
| 28 | PRPF4B | 1.30200434 |
| 29 | LATS2 | 1.28460837 |
| 30 | ICK | 1.25830378 |
| 31 | CDK6 | 1.24415663 |
| 32 | TGFBR2 | 1.22766331 |
| 33 | FGFR2 | 1.18848510 |
| 34 | RPS6KA2 | 1.18189323 |
| 35 | MAPK11 | 1.18079782 |
| 36 | INSRR | 1.17667965 |
| 37 | MTOR | 1.17255075 |
| 38 | EPHB1 | 1.15750743 |
| 39 | FER | 1.14327197 |
| 40 | ERBB2 | 1.12748947 |
| 41 | NEK9 | 1.11367003 |
| 42 | CAMK1D | 1.11126943 |
| 43 | MAP3K6 | 1.09510931 |
| 44 | LMTK2 | 1.08087345 |
| 45 | MAP3K3 | 1.04718329 |
| 46 | MAP2K4 | 1.03173738 |
| 47 | BMX | 1.02780467 |
| 48 | TESK1 | 1.01254324 |
| 49 | PRKD2 | 1.00416075 |
| 50 | PAK2 | 0.99970244 |
| 51 | MAP2K3 | 0.97074635 |
| 52 | FGFR1 | 0.94925136 |
| 53 | MARK2 | 0.94542279 |
| 54 | DYRK1B | 0.94358555 |
| 55 | STK3 | 0.91174333 |
| 56 | TAOK3 | 0.88879323 |
| 57 | CDK4 | 0.88380403 |
| 58 | MAP3K7 | 0.86722195 |
| 59 | TGFBR1 | 0.85824368 |
| 60 | ABL2 | 0.84518869 |
| 61 | DMPK | 0.83959185 |
| 62 | GSK3A | 0.82450782 |
| 63 | IRAK3 | 0.77985063 |
| 64 | TYK2 | 0.77823579 |
| 65 | PIK3CG | 0.75310798 |
| 66 | RPS6KL1 | 0.72331965 |
| 67 | RPS6KC1 | 0.72331965 |
| 68 | DDR2 | 0.71544929 |
| 69 | NEK1 | 0.70934380 |
| 70 | PRKAA2 | 0.69270493 |
| 71 | RPS6KB2 | 0.68066245 |
| 72 | EEF2K | 0.67445341 |
| 73 | FRK | 0.66489802 |
| 74 | PDPK1 | 0.65461427 |
| 75 | MAP2K2 | 0.64685508 |
| 76 | JAK2 | 0.64311286 |
| 77 | STK38 | 0.63430964 |
| 78 | LRRK2 | 0.62491714 |
| 79 | ILK | 0.59271313 |
| 80 | MAP3K1 | 0.57941469 |
| 81 | DAPK2 | 0.57478046 |
| 82 | CAMK1G | 0.57066864 |
| 83 | MAP3K11 | 0.55373730 |
| 84 | ROCK2 | 0.55289079 |
| 85 | MAP2K1 | 0.54449750 |
| 86 | TYRO3 | 0.54161542 |
| 87 | MAP3K8 | 0.54002514 |
| 88 | MYLK | 0.53967409 |
| 89 | KSR2 | 0.53745422 |
| 90 | FGFR3 | 0.53077499 |
| 91 | MAPK15 | 0.52346751 |
| 92 | PRKD3 | 0.51622946 |
| 93 | RET | 0.51590373 |
| 94 | ROCK1 | 0.51561638 |
| 95 | RPS6KA6 | 0.49115180 |
| 96 | CSK | 0.48078782 |
| 97 | HIPK2 | 0.48077240 |
| 98 | EPHA3 | 0.47841854 |
| 99 | MAPKAPK3 | 0.45678056 |
| 100 | TRPM7 | 0.45197509 |
| 101 | PRKD1 | 0.43211275 |
| 102 | STK10 | 0.43000680 |
| 103 | ZAP70 | 0.42453598 |
| 104 | PTK2B | 0.41823877 |
| 105 | PRKCZ | 0.41545807 |
| 106 | CDK7 | 0.41126461 |
| 107 | EGFR | 0.40928215 |
| 108 | SRC | 0.40573466 |
| 109 | MAP3K13 | 0.39629948 |
| 110 | CHUK | 0.38730781 |
| 111 | PAK3 | 0.38267940 |
| 112 | CDK9 | 0.38212754 |
| 113 | PRKACG | 0.37705506 |
| 114 | GRK6 | 0.37618084 |
| 115 | TTK | 0.36632821 |
| 116 | AKT2 | 0.36469972 |
| 117 | PRKAA1 | 0.36306018 |
| 118 | TAOK2 | 0.36216270 |
| 119 | CSNK1G1 | 0.36189255 |
| 120 | MAPK4 | 0.34014266 |
| 121 | TBK1 | 0.31009656 |
| 122 | PDGFRB | 0.30930941 |
| 123 | IGF1R | 0.30120095 |
| 124 | PRKG2 | 0.29335391 |
| 125 | JAK1 | 0.28842589 |
| 126 | LIMK1 | 0.28506336 |
| 127 | DAPK3 | 0.27934927 |
| 128 | MAP3K2 | 0.27243659 |
| 129 | MAPK1 | 0.27020023 |
| 130 | MAPK7 | 0.27018726 |
| 131 | MAPKAPK2 | 0.26751357 |
| 132 | NEK2 | 0.26577548 |
| 133 | JAK3 | 0.25409362 |
| 134 | MAPK12 | 0.24722584 |
| 135 | CSNK1A1L | 0.23864581 |
| 136 | INSR | 0.23423850 |
| 137 | ARAF | 0.23235988 |
| 138 | CSNK1E | 0.22931314 |
| 139 | RPS6KA1 | 0.22301175 |
| 140 | MAPK10 | 0.20335490 |
| 141 | SGK3 | 0.19521777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.35173531 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.82123828 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39001015 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.35344907 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.15927827 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.86041793 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.65480235 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.60648249 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.60410269 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58058886 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52741412 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31296875 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.13730845 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.97371883 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.96467094 |
| 16 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.96306011 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.94859570 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.88293532 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87435354 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.86937675 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84864473 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.83231643 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.81846228 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.80703947 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.77248838 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.75185271 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.75005138 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.74018528 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.72209794 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67692127 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.63596932 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.63511686 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61390956 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60689786 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55201537 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.54926924 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.53733423 |
| 38 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.49841370 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39752854 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37709529 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.37147546 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33348752 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.25804647 |
| 44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.25042384 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.24174181 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.22873885 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21299433 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.20569327 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19837250 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19826751 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19672982 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.17026059 |
| 53 | Thyroid cancer_Homo sapiens_hsa05216 | 1.14660725 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 1.12333476 |
| 55 | Tight junction_Homo sapiens_hsa04530 | 1.11964944 |
| 56 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.11472740 |
| 57 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.08115082 |
| 58 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.07687435 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 1.07078206 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06617118 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.05262530 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03205394 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.99415244 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96426954 |
| 65 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.96332159 |
| 66 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.95169123 |
| 67 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.94573191 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93340927 |
| 69 | Axon guidance_Homo sapiens_hsa04360 | 0.91487149 |
| 70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89109062 |
| 71 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88818322 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87509282 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86556698 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85642256 |
| 75 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.85522254 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83955140 |
| 77 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79355606 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.76848650 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75645993 |
| 80 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.75334782 |
| 81 | Glioma_Homo sapiens_hsa05214 | 0.75039864 |
| 82 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.71563652 |
| 83 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71138896 |
| 84 | Pathways in cancer_Homo sapiens_hsa05200 | 0.70806027 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70549815 |
| 86 | Melanogenesis_Homo sapiens_hsa04916 | 0.69847969 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69154810 |
| 88 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.68351373 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67581668 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67509964 |
| 91 | Prostate cancer_Homo sapiens_hsa05215 | 0.67150118 |
| 92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66980100 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65021281 |
| 94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63032675 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62973069 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58296460 |
| 97 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58259505 |
| 98 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.57637517 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56326267 |
| 100 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54916785 |
| 101 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54566793 |
| 102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54548040 |
| 103 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.51897179 |
| 104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50196894 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.39476848 |
| 106 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.39245959 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.39238354 |
| 108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32999266 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31869291 |
| 110 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29395196 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24846102 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.19575848 |
| 113 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18761074 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.18126476 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.17737542 |
| 116 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16318678 |
| 117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.14025356 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.13175148 |
| 119 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.13128911 |
| 120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.10910232 |
| 121 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.09154807 |
| 122 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.07496854 |
| 123 | Focal adhesion_Homo sapiens_hsa04510 | 0.06273537 |
| 124 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.04205391 |
| 125 | Adherens junction_Homo sapiens_hsa04520 | 0.03569173 |
| 126 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 0.02644965 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.00398111 |
| 128 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.00075303 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0969674 |
| 130 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0938938 |
| 131 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0881319 |
| 132 | Notch signaling pathway_Homo sapiens_hsa04330 | -0.0549112 |
| 133 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0460752 |
| 134 | Hippo signaling pathway_Homo sapiens_hsa04390 | -0.0412952 |
| 135 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | -0.0409584 |
| 136 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0195883 |
| 137 | Proteoglycans in cancer_Homo sapiens_hsa05205 | -0.0189600 |
| 138 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0114636 |

